High-risk mitral valve replacement in severe pulmonary hypertension - 30 years experience

European Journal of Cardio-thoracic Surgery

Volumn 13, Issue 4, 1998, Pages 344-352

  Cesnjevar, Robert A ^a   Feyrer, Richard ^a   Walther, Friedrich ^a   Mahmoud, Faidi O ^a   Lindemann, Yvonne ^a   Von Der Emde, Juergen ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Long term results; Mitral valve replacement; Pulmonary hypertension

Indexed keywords

ADULT; AGED; ANTICOAGULATION; ARTICLE; EXPERIENCE; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; LONG TERM CARE; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; MONITORING; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REOPERATION;

ADULT; BIOPROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; HYPERTENSION, PULMONARY; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; REOPERATION; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032051592     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(98)00042-6     Document Type: Article

References (26)

1. [1] Starr A, Edwards ML. Mitral replacement: clinical experience with a ball valve prosthesis. Ann Surg 1961;154:726-40.
2. [2] Cevese PG, Gallucci V, Valfre C, Giacomin A, Mazzucco A, Casarotto D. Pulmonary hypertension in mitral valve surgery. J Cardiovasc Surg Torino 1980;21(1):7-10.
3. [3] Jegaden O, Rossi R, Delahaye F, Montagna P, Delaye J, Delahaye JP, Mikaeloff P. Mitral valve replacement in severe pulmonary hypertension. Long-term results. Arch Mal Coeur Vaiss 1991;84(9):1297-301.
4. [4] Pasaoglu I, Demircin M, Dogan R, Ozmen F, Ersoy U, Boke E, Bozer AY. Mitral valve surgery in the presence of pulmonary hypertension. Jpn Heart J 1992;33(2):179-84.
5. [5] Shigenobu M, Senoo Y, Teramoto S. Factors influencing long-term survival after mitral valve replacement. Acta Med Okayama 1981;35(5):363-72.
6. [6] Vincens JJ, Temizer D, Post JR, Edmunds LH Jr., Herrmann HC. Long-term outcome of cardiac surgery in patients with mitral stenosis and severe pulmonary hypertension. Circulation 1995;1(92 (9 Suppl):II137-42.
7. [7] Eberlein U, von der Emde J, Rein J, Esperer HD. Thromb-embolic and bleeding complications after mitral valve replacement. Eur J Cardio-thorac Surg 1990;4(II):605-12.
8. [8] Edmunds LH, Clark RE, Cohn LH, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1988;46:257-9.
9. [9] Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1953;53:457-66.
10. [10] Chen EP, Bittner HB, Davis RD, Van Trigt P. Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann Thorac Surg 1997;63(3):814-21.
11. [11] D'Ambra MN, LaRaia PJ, Philibin DM, Watkins WD, Hilgenberg AD, Buckley MJ. Prostaglandin E1. A new therapy for refractory right heart failure and pulmonary hypertension after mitral valve replacement. J Thorac Cardiovasc Surg 1985;89(4):567-72.
12. [12] Girard C, Lehot JJ, Pannetier JC, Filley S, Ffrench P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology 1992;77(5):880-3.
13. [13] Kirklin JW, Barratt-Boyes BG. Mitral valve disease with or without tricuspid valve disease. In: Kirklin JW, Barratt-Boyes BG, editors. Cardiac Surgery, 2nd edn. New York: Churchill Livingstone, 1993:425-89.
14. [14] Halperin JL, Brooks KM, Rothlauf EB, Mindich BP, Ambrose JA, Teichholz LE. Effect of nitroglycerin on the pulmonary venous gradient in patients after mitral valve replacement. J Am Coll Cardiol 1985;5(1):34-9.
15. [15] Foltz BD, Hessel EA II, Ivey TD. The early course of pulmonary artery hypertension in patients undergoing mitral valve replacement with cardioplegic arrest. J Thorac Cardiovasc Surg 1984;88(2):238-47.
16. [16] Tryka AF, Godleski JJ, Schoen FJ, Vandevanter SH. Pulmonary vascular disease and hypertension after valve surgery for mitral stenosis. Hum Pathol 1985;16(1):65-71.
17. [17] Kaul TK, Bain WH, Jones JV, Lorimer AR, Thomson RM, Turner MA, Escarous A. Mitral valve replacement in the presence of severe pulmonary hypertension. Thorax 1976;31(3):332-6.
18. [18] McIlduff JB, Daggett WM, Buckley MJ, Lappas DG. Systemic and pulmonary hemodynamic changes immediately following mitral valve replacement in man. J Cardiovasc Surg Torino 1980;21(3):261-6.
19. [19] Harpole DH, Rankin JS, Wolfe WG, Clements FM, Frigt Young WG, Jones RH. Effects of standard mitral valve replacement on left ventricular function. Ann Thorac Surg 1990;49:866-74.
20. [20] Kennedy JW, Doces JG, Stewart DK. Left ventricular function before and following surgical treatment of mitral valve disease. Am Heart J 1979;97:592-8.
21. [21] Hetzer R, Bougioukas G, Franz M, Borst HG. Mitral valve replacement with preservation of papillary muscles and chordae tendineae - Revival of a seemingly forgotten concept. I. Preliminary clinical report. Thorac Cardiovasc Surg 1983;31(5):291-6.
22. [22] Hansen DE, Sariis GE, Niczyporuk MA, Derby GC, Cahill F, Miller DC. Physiologic role of the mitral apparatus in left ventricular regional mechanics, contraction synergy, and global systolic performance. J Thorac Cardiovasc Surg 1989;97:521-33.
23. [23] Horstkotte D, Haerten K, Herzer JA, Siepel L, Bircks W, Loogen F. Preliminary results in mitral valve replacement with the St. Jude Medical prostheses: comparison with the Björk-Shiley valve. Circulation 1981;64(suppl. II):203-9.
24. [24] Horstkotte D, Haerten K, Herzer JA, Siepel L, Bircks W, Loogen F. Preliminary clinical and hemodynamic results after mitral valve replacement using St. Jude Medical prostheses in comparison with the Björk-Shiley valve. Thorac Cardiovasc Surg 1981;29:93-9.
25. [25] Horstkotte D, Haerten K, Seipel L, Korfer R, Budde T, Bircks W, Loogen F. Central hemodynamics at rest and during exercise after mitral valve replacement with different prostheses. Circulation 1983;68(suppl. II):161-8.
26. [26] Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin. J Thorac Cardiovasc Surg 1989;97(3):364-72.